Developer docs
API playgroundTry for free, no card

Search company profiles

Fresenius Group

Full company profile

uuid003ism8

Namestring
Fresenius Group
Websiteurl
karriere.fresenius.de
Company typeenum
Private
Founded yearint
1912
Descriptiontext

Fresenius Group is a Germany-headquartered, for-profit healthcare company founded in 1912 and based in Bad Homburg, providing products and services across three operational verticals: dialysis, hospitals, and the medical care of patients at home. The firm employs more than 10,000 people and operates as a single corporate entity spanning institutional, specialty clinical, and home-based care settings, suggesting an integrated care-delivery and medical-products platform rather than a single-product business. Revenue, customer segmentation, pricing mechanics, and geographic markets served are not disclosed in the available source data, and the company is marked as private in firmographic records.

Leadership is concentrated in a Chairman-and-CEO structure, with Michael Sen serving as Chairman and CEO of the Management Board. No further management-team detail, M&A history, funding history, product roadmap, partnership portfolio, or operational geography breakdown is available in the input; consequently, the business-model description above is necessarily limited to the three service lines and the consolidated corporate structure that the data confirms. The careers portal at karriere.fresenius.de is the only externally referenced channel in the source material, pointing to an active but undisclosed hiring footprint in Germany and adjacent markets.

Short descriptiontext

Fresenius Group is a Germany-headquartered healthcare company, founded in 1912 and headquartered in Bad Homburg, providing products and services for dialysis, hospitals, and home-based patient medical care, with 10,000+ employees under Chairman and CEO Michael Sen.

Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersBad Homburg, Germany
HQ citystring
Bad Homburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
dialysis services, hospital products, home medical care, patient care, healthcare services
Industry6 codes
1Dialysis Services (Hemodialysis & Peritoneal Dialysis)
CodeHLAKAHACPrimaryYes
2Peritoneal Dialysis (PD) Systems & Supplies
CodeHLAHAKABPrimaryNo
3Home Infusion Therapy Providers
CodeHLAFAEAEPrimaryNo
4Hospital Shared Services, GPOs & System Support Organizations
CodeHLAFAAAOPrimaryNo
5Outpatient Dialysis & Kidney Care Centers
CodeHLAFABAEPrimaryNo
6Home Dialysis Equipment & Remote Monitoring
CodeHLAHAKAGPrimaryNo
NAICS code3 codes
  • Kidney Dialysis Centers621492
  • Ambulatory Health Care Services621
  • Services for the Elderly and Persons with Disabilities62412
SIC code3 codes
  • Services-Home Health Care Services8082
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Healthcare Services
No data
Cost components4 values
Personnel, Supply Chain, Operations, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Fresenius Group provides products and services for dialysis, hospitals, and the medical care of patients at home. The company operates across the continuum of care, supplying dialysis treatments and equipment to clinical settings, offering medical products and services to hospitals, and delivering home-based medical care services to patients.

Differentiator
Functional benefit
Problem solved
Product and service3 records
1Dialysis Products and Services
CategoryDialysis
2Hospital Products and Services
3Home Medical Care
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
1DaVita
TypeDirect peer
Description

The largest direct competitor to Fresenius in outpatient kidney dialysis services globally, operating thousands of dialysis centers and increasingly competing in home dialysis and integrated kidney care.

2Owens & Minor
TypeBroad incumbent
Description

A distributor of medical and surgical supplies to hospitals and home-health providers, sharing Fresenius' hospital and home-care distribution footprint and customer base.

3Baxter International
TypeDirect peer
Description

A major medical products peer overlapping with Fresenius on peritoneal dialysis (PD) systems, renal replacement therapies, IV solutions, and hospital infusion products used across Fresenius' service and home-care lines.

4Siemens Healthineers
TypeBroad incumbent
Description

A broader incumbent in hospital-facing medical technology, imaging, and diagnostics; overlaps with Fresenius' hospital products business as both supply integrated solutions to acute care providers and large health systems.

5Medtronic
TypeBroad incumbent
Description

A broad medical device incumbent overlapping with Fresenius in hospital-based therapeutic and monitoring devices, and a potential competitor as Medtronic expands into chronic disease and connected care solutions.

6B. Braun
TypeDirect peer
Description

A German-headquartered medical device and pharmaceutical company with overlapping exposure to dialysis (hemodialysis machines and consumables), infusion therapy, and hospital supplies comparable to Fresenius' multi-segment portfolio.

7Becton Dickinson (BD)
TypeBroad incumbent
Description

A large diversified medical device company supplying infusion systems, injection devices, and clinical consumables to hospitals and home-care settings — comparable to Fresenius' hospital supplies and home infusion exposure.

8CVS Health (Kidney Care / Oak Street)
TypeEmerging player
Description

An emerging value-based kidney care player building integrated primary care plus dialysis delivery; represents a newer threat to Fresenius' dialysis clinic model by aggregating ESRD patients under risk-bearing arrangements.

9U.S. Renal Care
TypeDirect peer
Description

A US-focused dialysis services provider offering in-center and home hemodialysis and peritoneal dialysis, directly overlapping with Fresenius' core clinic-and-home dialysis delivery model.

10Diaverum
TypeDirect peer
Description

A global dialysis services operator with clinics across Europe, Latin America, the Middle East and Asia, directly comparable to Fresenius' clinic-based dialysis services business and patient population served.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fresenius Group

Healthcare Serviceskarriere.fresenius.de

Fresenius Group is a Germany-headquartered healthcare company, founded in 1912 and headquartered in Bad Homburg, providing products and services for dialysis, hospitals, and home-based patient medical care, with 10,000+ employees under Chairman and CEO Michael Sen.

What Fresenius Group does

Fresenius Group is a Germany-headquartered, for-profit healthcare company founded in 1912 and based in Bad Homburg, providing products and services across three operational verticals: dialysis, hospitals, and the medical care of patients at home. The firm employs more than 10,000 people and operates as a single corporate entity spanning institutional, specialty clinical, and home-based care settings, suggesting an integrated care-delivery and medical-products platform rather than a single-product business. Revenue, customer segmentation, pricing mechanics, and geographic markets served are not disclosed in the available source data, and the company is marked as private in firmographic records.

Leadership is concentrated in a Chairman-and-CEO structure, with Michael Sen serving as Chairman and CEO of the Management Board. No further management-team detail, M&A history, funding history, product roadmap, partnership portfolio, or operational geography breakdown is available in the input; consequently, the business-model description above is necessarily limited to the three service lines and the consolidated corporate structure that the data confirms. The careers portal at karriere.fresenius.de is the only externally referenced channel in the source material, pointing to an active but undisclosed hiring footprint in Germany and adjacent markets.

Fresenius Group firmographics

Firmographics
Name
Fresenius Group
Website
https://karriere.fresenius.de
Company type
Private
Founded year
1912
Headcount range
5,001–10,000 employees
Short description
Fresenius Group is a Germany-headquartered healthcare company, founded in 1912 and headquartered in Bad Homburg, providing products and services for dialysis, hospitals, and home-based patient medical care, with 10,000+ employees under Chairman and CEO Michael Sen.
Ownership category
akta.pro rank

Fresenius Group industry classification

Industry
Product category
Healthcare Services
NAICS
Kidney Dialysis Centers (621492), Ambulatory Health Care Services (621), Services for the Elderly and Persons with Disabilities (62412)
SIC
Services-Home Health Care Services (8082), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC)
akta.pro secondary industries
Peritoneal Dialysis (PD) Systems & Supplies (HLAHAKAB), Home Infusion Therapy Providers (HLAFAEAE), Hospital Shared Services, GPOs & System Support Organizations (HLAFAAAO), Outpatient Dialysis & Kidney Care Centers (HLAFABAE), Home Dialysis Equipment & Remote Monitoring (HLAHAKAG)

Keywords

  • Dialysis services
  • Hospital products
  • Home medical care
  • Patient care
  • Healthcare services

Where Fresenius Group is headquartered

Location

Headquarters

HQ city
Bad Homburg
HQ country
Germany
HQ region
Europe

Markets served

Fresenius Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Technology or R&D

Fresenius Group product offering

Product offering

Core offering

Fresenius Group provides products and services for dialysis, hospitals, and the medical care of patients at home. The company operates across the continuum of care, supplying dialysis treatments and equipment to clinical settings, offering medical products and services to hospitals, and delivering home-based medical care services to patients.

Differentiator

Problem solved

Functional benefit

Products and services

  • Dialysis Products and Services
  • Hospital Products and Services
  • Home Medical Care

Companies that use Fresenius Group

Customer profile

Ideal customer profiles2 records

Fresenius Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Fresenius Group partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights2 records

Fresenius Group competitors and assessment

Company assessment

Direct peers

  • DaVita: The largest direct competitor to Fresenius in outpatient kidney dialysis services globally, operating thousands of dialysis centers and increasingly competing in home dialysis and integrated kidney care.
  • Baxter International: A major medical products peer overlapping with Fresenius on peritoneal dialysis (PD) systems, renal replacement therapies, IV solutions, and hospital infusion products used across Fresenius' service and home-care lines.
  • B. Braun: A German-headquartered medical device and pharmaceutical company with overlapping exposure to dialysis (hemodialysis machines and consumables), infusion therapy, and hospital supplies comparable to Fresenius' multi-segment portfolio.
  • U.S. Renal Care: A US-focused dialysis services provider offering in-center and home hemodialysis and peritoneal dialysis, directly overlapping with Fresenius' core clinic-and-home dialysis delivery model.
  • Diaverum: A global dialysis services operator with clinics across Europe, Latin America, the Middle East and Asia, directly comparable to Fresenius' clinic-based dialysis services business and patient population served.

Broad incumbents

  • Owens & Minor: A distributor of medical and surgical supplies to hospitals and home-health providers, sharing Fresenius' hospital and home-care distribution footprint and customer base.
  • Siemens Healthineers: A broader incumbent in hospital-facing medical technology, imaging, and diagnostics; overlaps with Fresenius' hospital products business as both supply integrated solutions to acute care providers and large health systems.
  • Medtronic: A broad medical device incumbent overlapping with Fresenius in hospital-based therapeutic and monitoring devices, and a potential competitor as Medtronic expands into chronic disease and connected care solutions.
  • Becton Dickinson (BD): A large diversified medical device company supplying infusion systems, injection devices, and clinical consumables to hospitals and home-care settings — comparable to Fresenius' hospital supplies and home infusion exposure.

Emerging players

  • CVS Health (Kidney Care / Oak Street): An emerging value-based kidney care player building integrated primary care plus dialysis delivery; represents a newer threat to Fresenius' dialysis clinic model by aggregating ESRD patients under risk-bearing arrangements.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Fresenius Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fresenius Group leadership team

Management profile

Number of profiles

Profiles1 record

Fresenius Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fresenius Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fresenius Group

What does Fresenius Group do?

Fresenius Group provides products and services for dialysis, hospitals, and the medical care of patients at home. The company operates across the continuum of care, supplying dialysis treatments and equipment to clinical settings, offering medical products and services to hospitals, and delivering home-based medical care services to patients.

When was Fresenius Group founded?

Fresenius Group was founded in 1912. It employs 5,001 to 10,000 people.

Where is Fresenius Group based?

Fresenius Group is headquartered in Bad Homburg, Germany, in the Europe region.

Who are Fresenius Group's main competitors?

Direct peers on record are DaVita, Baxter International, B. Braun, U.S. Renal Care and Diaverum. Broad incumbents are Owens & Minor, Siemens Healthineers, Medtronic and Becton Dickinson (BD). CVS Health (Kidney Care / Oak Street) is listed as an emerging player.

Does Fresenius Group have an API?

No public API is recorded for Fresenius Group.

What industry is Fresenius Group in?

Fresenius Group's product category is Healthcare Services. Its primary akta.pro industry code is HLAKAHAC, Dialysis Services (Hemodialysis & Peritoneal Dialysis), with a secondary code of HLAHAKAB, Peritoneal Dialysis (PD) Systems & Supplies. Its NAICS code is 621492 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinanzNachrichten.deXFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 12.08.2026Boerse Frankfurt announced that several financial instruments, including those from Fresenius SE & Co. KGaA and Intuitive Investment Group, will have their last trading day on August 12, 2026. This deletion removes these specific securities from the exchange's listing. The move represents a routine administrative update regarding the delisting of these particular assets.PR NewswireDialysis Industry Sets National Spending Record by Committing $111 Million to Oppose Prop. 8, Protect Billions in Profits - Reports Californians for Kidney Dialysis Patient ProtectionDialysis corporations DaVita and Fresenius have committed $111 million to defeat California's Proposition 8, setting a record as the most one side has ever spent against a ballot initiative in the United States. Polling indicates the race remains a statistical tie despite the spending disparity, with the "Yes on Prop. 8" side being outspent more than five to one. Proposition 8 would limit dialysis corporations' revenues to 15 percent above patient care spending, potentially affecting the $4 billion in combined profits the two companies made from U.S. dialysis operations in 2017.PR NewswireGlobal Private Healthcare Markets 2016-2024: Strategic Business Report 2018 -- Ballooning Elderly Population: A Key Growth DriverResearchAndMarkets has added the "Private Healthcare - Global Strategic Business Report" to its offerings, providing comprehensive analytics and forecasts for the global private healthcare market from 2016 through 2024. The report profiles 120 companies, including key players such as Apollo Hospitals Enterprise Ltd., Fresenius SE & Co. KGaA, and Spire Healthcare Group Plc., while analyzing regional markets across the US, Europe, Asia-Pacific, and other regions.PR NewswireGlobal Market Study on Disposable Blood Bags: Increasing Tender Based Procurement of Blood Collection Bags by Not-For-Profit Organizations and Public Healthcare Facilities to Drive Market by 2024Persistence Market Research published a report analyzing the global disposable plastic blood bags market from 2016 to 2024, highlighting growth driven by rising demand for blood products and increasing tender-based procurement. The study identifies key market players such as Fresenius SE & Co. KGaA, Terumo Corporation, and Grifols, S.A., noting their strategic focus on partnerships with hospitals and blood banks. It segments the market by product type, sales channel, end user, and region to forecast value and volume trends.